articleSpineDec 6, 2011Closed access

The Burden of Chronic Low Back Pain

Avalon Pharma (United States) · Zen-Noh (Japan)

PubMed
Indexed incrossrefpubmed

Abstract

Objective

To examine the comorbidities, treatment patterns, health care resource utilization, and direct medical costs of patients with chronic low back pain (CLBP) in clinical practice. SUMMARY OF BACKGROUND DATA: Although the socioeconomic impact of CLBP is substantial, characterization of comorbidities, pain-related pharmacotherapy, and health care resource use/costs of patients with CLBP relative to non-CLBP controls have been infrequently documented.

Methods

Using the LifeLink Health Plan Claims Database (IMS Health Inc., Watertown, MA), patients with CLBP, defined using the International Classification of Diseases, Ninth Revision, Clinical Modification, were identified and matched (age, sex, and region) with non-CLBP individuals. Comorbidities, pain-related pharmacotherapy, and health care service use/costs (pharmacy, outpatient, inpatient, total) were compared for the 2 groups during 2008.

Citation impact

634
total citations
FWCI
22.04
Percentile
100%
References
48
Citations per year

Authors

5

Topics & keywords

Keywords
  • Medicine
  • Pharmacotherapy
  • Comorbidity
  • Fibromyalgia
  • Physical therapy
  • Pharmacy
  • Low back pain
  • Chronic pain
No related works found for this paper.